Insurance and racial disparities in palliative care utilization and end-of-life outcomes in metastatic pancreatic cancer: A national analysis.
Abstract
e16439 Background: Disparities in palliative care access and end-of-life (EOL) care intensity by insurance and race in metastatic pancreatic cancer remain poorly characterized nationally. Methods: Using the National Inpatient Sample (2019-2022), we identified hospitalizations for metastatic pancreatic cancer (ICD-10: C25.x with C77-C79). Outcomes included palliative care consultation (Z51.5), aggressive EOL care (mechanical ventilation, CPR, vasopressors, dialysis), and in-hospital mortality. Multivariable logistic regression estimated adjusted odds ratios (aOR) by insurance and race. Mediation analysis assessed whether palliative care explained insurance-mortality associations. Results: Among 236,160 hospitalizations (mean age 67.6 years), mortality was 9.6%, palliative care occurred in 27.0%, and aggressive EOL care in 8.0%. Uninsured patients had higher palliative care (aOR 1.43, p < 0.001) yet higher mortality (aOR 1.46, p < 0.001) versus privately insured; palliative care mediated ~40% of this disparity. Medicare patients had lower palliative care (aOR 0.88) and lower mortality (aOR 0.77). Black patients had 70% higher aggressive EOL care odds (aOR 1.70, p < 0.001) despite higher palliative care rates (aOR 1.13). Hispanic and Asian patients showed 44% and 61% higher aggressive EOL care odds, respectively. Conclusions: Uninsured patients receive more palliative consultations yet have higher mortality, suggesting reactive rather than proactive engagement. Black patients experience 70% higher aggressive EOL interventions despite similar palliative exposure. Findings support early palliative integration and culturally-concordant goals-of-care conversations for equitable EOL care. Palliative care disparities. Outcome/Subgroup N Private (%) Medicare (%) Medicaid (%) Uninsured (%) aOR vs Private 95% CI P-value Key Finding Overall Cohort 236,160 — — — — — — — Mean age 67.6y; 65.8% liver mets PALLIATIVE CARE CONSULTATION By Insurance 236,160 23.7 26.8 28.4 32.0 1.43 (Unins) 1.33-1.53 <0.001 Uninsured 43% higher IN-HOSPITAL MORTALITY By Insurance 236,160 10.3 8.5 11.0 14.5 1.46 (Unins) 1.32-1.61 <0.001 Uninsured 46% higher After Palliative Adjustment — — — — — 1.26 (Unins) 1.14-1.40 <0.001 ~40% mediated AGGRESSIVE EOL CARE (Race) Black vs White 236,160 6.7 (W) — — 11.3 (B) 1.70 1.63-1.77 <0.001 70% higher in Black pts Hispanic/Asian vs White — 6.7 (W) — — 10.1/11.7 1.44/1.61 1.37-1.52/1.50-1.72 <0.001 44-61% higher
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (3)
Lawin Steve Mathew Lasington
Rutger's University, East Hanover, NJ
Jeril Lasington
The New York Medical College Graduate Medical Education Program at St. Mary’s General Hospital and St. Clare’s Health, Denville, NJ
Swamynathan Umamaheswaran
Personio, New York, NY